CID is 2794
synonyms found at PubChem are:
clofazimine, 2030-63-9, Lamprene, Lampren, Chlofazimine, Clofazimina, Clofaziminum, B 663 (Pharmaceutical), Clofaziminum [INN-Latin], Clofazimina [INN-Spanish], B-663, NSC-141046, G 30320, Riminophenazine, UNII-D959AE5USF, B 663 (VAN), Lamprene (TN), C27H22Cl2N4, 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin, Clofazimine [USAN:INN:BAN], B 663, 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine, 3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine, B 663, pharmaceutical, EINECS 217-980-2, NSC 141046, BRN 0060420, D959AE5USF, Clofazimine (JAN/USP/INN), CHEBI:3749, N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine, CHEMBL1083384, Liposome-encapsulated clofazimine, G-30320, G-30,320, 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-, 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-, N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine, NSC141046, 3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German], Phenazine, 2,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-, Phenazine, 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-, SMP2_000339, NCGC00016600-01, CPD000058704, CAS-2030-63-9, N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine, B. 663, N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine, 2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-, 3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine, (E)-N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine, N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine, N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropyliaino)phenazin-2-amine, N,5-bis(4-chlorophenyl)-3-[(propan-2-yl)imino]-3,5-dihydrophenazin-2-amine, (3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine, CFZ, SMR000058704, SR-05000001807, Clofazimin, (3E)-N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine, Clofazimine [USAN:USP:INN:BAN], Prestwick_685, (non-d)Clofazimine-d7, B663, AC1L1EHE, Prestwick0_000376, Prestwick1_000376, Prestwick2_000376, Prestwick3_000376, DSSTox_CID_2839, D07NPR, D0S5UH, cid_2794, CHEMBL1292, DSSTox_RID_76752, BIDD:PXR0147, DSSTox_GSID_22839, SCHEMBL26757, SCHEMBL26758, BSPBio_000531, 4-25-00-03033 (Beilstein Handbook Reference), MLS000028617, MLS001424318, MLS006010789, SPBio_002452, BPBio1_000585, GTPL9184, SCHEMBL5663361, CHEMBL1369407, DTXSID7022839, CTK6H0611, MolPort-003-940-861, MolPort-042-621-745, WDQPAMHFFCXSNU-KRUMMXJUSA-N, HMS1569K13, HMS2052B05, HMS2093J10, HMS2096K13, HMS2231B04, HMS3370N05, HMS3394B05, HMS3652A16, HMS3713K13, KUC109573N, Pharmakon1600-01505974, BCP07792, HY-B1046, KS-00000XN9, KSC-27-052A, Tox21_110516, BDBM50318909, BDBM50378783, MFCD00056793, MMV687800, NSC759283, s4107, ZINC17953024, AKOS015896438, AKOS026749881, ZINC100037101, ZINC253916263, CCG-101159, CS-4567, DB00845, KS-1412, MCULE-1387160272, NC00409, NSC-759283, Riminophenazine (tuberculosis infection), NCGC00016600-02, NCGC00016600-03, NCGC00016600-04, NCGC00016600-05, NCGC00016600-07, NCGC00179529-01, AN-16626, SAM001246878, SC-47057, SMR004701474, Phenazine,10-dihydro-2-(isopropylimino)-, SBI-0206865.P001, LS-103014, FT-0657414, ST51014966, Z3118, C06915, D00278, 030C639, A814428, I06-1891, J-013203, SR-05000001807-1, SR-05000001807-2, BRD-K56614220-001-10-9, Z2037279473, Clofazimine, European Pharmacopoeia (EP) Reference Standard, N,5-bis(4-chlorophenyl)-3-isopropylimino-phenazin-2-amine, N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-2-phenazinamine, N,5-bis(4-chlorophenyl)-3-propan-2-ylimino-phenazin-2-amine, Clofazimine, United States Pharmacopeia (USP) Reference Standard, 2-p-Chloranilino-5-p-chlorphenyl-3,5-dihydro-3-isopropylimino-phenazin, 2-p-chloroanilino-5-p-chlorophenyl-3,5-dihydro-3-isopropyliminophenazine, N,5-bis(4-chlorophenyl)-3-(isopropylimino)-3,5-dihydrophenazin-2-amine, (4-Chloro-phenyl)-[5-(4-chloro-phenyl)-3-isopropylimino-3,5-dihydro-phenazin-2-yl]-amine, 2-Phenazinamine,5-bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-, 2-Phenazinamine,5-dihydro-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-, Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard, N,5-Bis(4-chlorophenyl)-3-([1-methylethyl]imino)-3,5-dihydro-2-phenazinamine #, Phenazine,10-dihydro-3-(p-chloroanilino)-10-(p-chlorophenyl)-2-(isopropylimino)-, Riminophenazine (tuberculosis infection), TB Alliance/IMM/BTTTRI/University of Illinois, (4-chlorophenyl)[5-(4-chlorophenyl)-3-(2-methyl-1-azapropylidene)(5-hydrophena zin-2-yl)]amine, Riminophenazines (Mycobacterium tuberculosis infection), The Global Alliance for TB Drug Development/Institute of Materia Medica